Antithrombin III Concentrates-Are they Clinically Useful?

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Thrombosis and Haemostasis

• Publication date

  1995-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0038-1653778PMID 7667814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Coagulation Disorder of Orthotopic Hepatic Transplantation

  2008cited by this paper
• Coagulation Abnormalities in Liver Disease

  2008cited by this paper
• [Antithrombin III substitution in dialysis-dependent renal insufficiency].

  2008cited by this paper
• [Congenital antithrombin III deficiency].

  1996cited by this paper
• Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli-asparaginase. A Gimema study

  1994cited by this paper
• Parvovirus B19 as a cause of acquired chronic pure red cell aplasia

  1994cited by this paper
• Thrombosis during Pregnancy and Surgery in Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S

  1994cited by this paper
• Inherited antithrombin III deficiency in the neonate.

  1994cited by this paper
• Modulation of coagulation and fibrinolysis in hepatic resection: a randomized prospective control study using antithrombin III concentrates.

  1994cited by this paper
• Intramuscular Dermatan Sulfate MF701 in Patients with Hip Fracture: Relationship between Pharmacokinetics and Antithrombotic Efficacy

  1994cited by this paper
• Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis.

  1994cited by this paper
• Evidence of a Hypercoagulable State in Patients with Acute Lymphoblastic Leukemia Treated with Low Dose of E.coli L-Asparaginase: A GIMEMA Study

  1993cited by this paper
• Controlled trial of antithrombin III supplementation in fulminant hepatic failure.

  1993cited by this paper
• Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.

  1993cited by this paper
• Supranormal antithrombin III levels induced by concentrate administration are ineffective in quenching thrombin generation in acute promyelocytic leukemia.

  1993cited by this paper
• Intravascular Coagulation in Liver Transplantation – Is It Present or Not?

  1993cited by this paper
• Congenital antithrombin III deficient neonate treated with antithrombin III concentrates.

  1993cited by this paper
• Orgaran (Org 10172) or Heparin for Preventing Venous Thrombosis after Elective Surgery for Malignant Disease? A Double-Blind, Randomised, Multicentre Comparison

  1993cited by this paper
• Heparin Therapy for Congenital Antithrombin III Deficiency in Pregnancy

  1993cited by this paper
• Myocardial infarction in a neonate with hereditary antithrombin III deficiency

  1993cited by this paper
• [Prophylactic use of concentrated antithrombin III preparation in children with nephrotic syndrome].

  1993cited by this paper
• [Neonatal testicular ischemic necrosis without torsion, associated with antithrombin III deficit].

  1993cited by this paper
• Reduction of Mortality with Antithrombin III in Septicemic Rats: A Study of Klebsiella pneumoniae Induced Sepsis

  1993cited by this paper
• Neonatal aortic thrombosis.

  1992cited by this paper
• Behandlung der Verbrauchskoagulopathie mit Antithrombin III-Konzentrat bei Kindern mit nachgewiesener Sepsis

  1992cited by this paper
• Effect of antithrombin concentrate on haemostatic variables in critically ill patients

  1992cited by this paper
• Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial.

  1992cited by this paper
• Coagulation abnormalities in liver disease.

  1992cited by this paper
• Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.

  1992cited by this paper
• Thrombosis of Left Heart in A Newborn

  1992cited by this paper
• Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.

  1992cited by this paper
• [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].

  1992cited by this paper
• Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance

  1992cited by this paper
• Letter to the editor: Prophylaxis of thromboembolism during pregnancy in hereditary AT‐III deficiency

  1992cited by this paper
• Safety of virus inactivated antithrombin III concentrate antithrombin III immuno (AT III).

  1992cited by this paper
• The pregnant antithrombin III deficient patient: management without antithrombin III concentrate.

  1992cited by this paper
• Treatment of Venous Thromboembolism in Patients with Congenital Deficiency of Antithrombin III

  1992influential reference
• A standard heparin nomogram for the management of heparin therapy.

  1991influential reference
• A pilot study of antithrombin replacement in intensive care management: the effects on mortality, coagulation and renal function

  1991cited by this paper
• Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipient's disease and use of antithrombin III concentrates. S. Orsola Working Group on Liver Transplantation.

  1991cited by this paper
• Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure

  1991cited by this paper
• Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysis.

  1991cited by this paper
• Virus Safety of Pasteurized Antithrombin III Concentrate

  1991cited by this paper
• 10 Anticoagulant therapy in venous thromboembolism

  1990cited by this paper
• Hypercoagulability during l‐asparaginase treatment: the effect of antithrombin III supplementation in vivo

  1990cited by this paper
• Thrombosis and Pregnancy in Congenital Deficiencies in AT III, Protein C or Protein S: Study of 78 Women

  1990cited by this paper
• Elimination of antithrombin III concentrate in healthy pregnant and preeclamptic women with an acquired antithrombin III deficiency.

  1990cited by this paper
• Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group.

  1990cited by this paper
• Pregnancy, antithrombin III deficiency and venous thrombosis: report of another case.

  1990cited by this paper
• Prevention of venous thrombosis after total hip arthroplasty: Francis CW, Pellegrini VD, Marder VJ, et al. J Bone Joint Surg 1989;71A:327–335

  1990cited by this paper
• Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40.

  1989cited by this paper
• Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.

  1989cited by this paper
• Neonatal antithrombin III deficiency.

  1989cited by this paper
• Congenital antithrombin III deficiency. Incidence and clinical features.

  1989cited by this paper
• Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.

  1989cited by this paper
• Purification and large-scale preparation of antithrombin III.

  1989cited by this paper
• Heat inactivation of human immunodeficiency virus in solutions of antithrombin III

  1989cited by this paper
• Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.

  1989cited by this paper
• Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.

  1989cited by this paper
• Anticoagulant therapy for venous thromboembolism.

  1989influential reference
• Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III

  1988cited by this paper
• Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III.

  1988cited by this paper
• Surgery in patients with congenital antithrombin III deficiency.

  1988cited by this paper
• Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.

  1988cited by this paper
• Management of Pregnancy in Women with Antithrombin III Congenital Defect: Report of Four Cases

  1988cited by this paper
• Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.

  1987cited by this paper
• RANDOMIZED TRIAL OF ANTITHROMBIN III VERSUS PLACEBO IN PATIENTS UNDERGOING PERITONEO-VENOUS SHUNT OPERATION

  1987cited by this paper
• Virus safety of a pasteurized antithrombin III concentrate. Preclinical and clinical data.

  1987cited by this paper
• Antithrombin III in Full-Term and Pre-Term Newborn Infants : Three Cases of Neonatal Diagnosis of AT III Congenital Defect

  1987cited by this paper
• Antithrombin III: Biodistribution in Healthy Volunteers

  1987cited by this paper
• Antithrombin III metabolism in two patients with a nephrotic syndrome caused by minimal chain nephritis and primary amyloidosis.

  1987cited by this paper
• [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis].

  1987cited by this paper
• Properties and catabolism of heat treated antithrombin III concentrate.

  1987cited by this paper
• Prophylactic use of antithrombin III concentrate following surgery in congenital antithrombin III deficiency.

  1987cited by this paper
• PROPERTIES AND VIRUS SAFETY OF A PASTEURIZED ANTITHROMBINIII-CONCENTRATE

  1987cited by this paper
• Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.

  1987cited by this paper
• Management of anti-thrombin III deficiency during pregnancy without administration of anti-thrombin III.

  1986cited by this paper
• Purified radiolabeled antithrombin III metabolism in three families with hereditary AT III deficiency: application of a three-compartment model.

  1986cited by this paper
• Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia.

  1986influential reference
• Thrombosis Prophylaxis in an AT III Deficient Pregnant Woman: Application of a Low Molecular Weight Heparinoid

  1986cited by this paper
• Hereditary antithrombin III deficiency and pregnancy: report of two cases and review of the literature.

  1985cited by this paper
• In vivo recovery of antithrombin concentrates.

  1985cited by this paper
• Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.

  1985cited by this paper
• Substitution of antithrombin III in shock and DIC: a randomized study.

  1985cited by this paper
• Hereditary antithrombin III deficiency and pregnancy: report of two cases and review of the literature.

  1985cited by this paper
• Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-III.

  1985cited by this paper
• Prophylaxis of thrombosis in antithrombin III-deficient women during pregnancy and delivery.

  1984cited by this paper
• Elimination of Intravenously Administered Radiolabelled Antithrombin III and Heparin in Humans

  1984cited by this paper
• Neonatal antithrombin III

  1984cited by this paper
• Effects of Human Antithrombin III on Mortality and Blood Coagulation Induced in Rabbits by Endotoxin

  1984cited by this paper
• [Effect of antithrombin III on experimental hepatotoxin poisoning in dogs].

  1984cited by this paper
• Antithrombin III concentrate as adjuvant in DIC treatment. A pilot study in 9 severely ill patients.

  1984cited by this paper
• Management of planned pregnancy in a patient with congenital antithrombin III deficiency

  1984cited by this paper
• The effect of platelet factor 4 (PF4) on assays of plasma heparin

  1984cited by this paper
• Severe acquired antithrombin III deficiency in relation to hepatic and renal insufficiency and intrauterine fetal death in late pregnancy.

  1983cited by this paper
• Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma.

  1983cited by this paper
• Treatment of DIC with antithrombin III concentrates.

  1983cited by this paper
• Antithrombin III Infusion in Patients Undergoing Peritoneovenous Shunt Operation: Failure in the Prevention of Disseminated Intravascular Coagulation

  1983influential reference
• Antithrombin-III-Substitution bei dialysepflichtiger Niereninsuffizienz*

  1982cited by this paper
• Antithrombin III transfusion in patients with hepatic cirrhosis

  1982cited by this paper

• Dry Gangrene of Feet in an Apparently Well Neonate.

  2023cites this paper
• Antithrombin III Supplementation in a Premature Infant: Is There a Target Antithrombin Level?

  2021cites this paper
• Shunt thrombosis in pediatric patients undergoing staged cardiac reconstruction for cyanotic congenital heart disease

  2020cites this paper
• Acute Kidney Injury in a Case of Purpura Fulminans Developing Secondary to Antithrombin 3 Deficiency.

  2018cites this paper
• Thrombectomy and Catheter-Directed Thrombolysis Combined With Antithrombin Concentrate for Treatment of Antithrombin Deficiency Complicated by Acute Deep Vein Thrombosis That Is Refractory to Anticoagulation.

  2016cites this paper
• Retrospective evaluation of antithrombin III supplementation in neonates and infants receiving enoxaparin for treatment of thrombosis

  2014cites this paper
• A clinical audit of antithrombin concentrate use in a tertiary paediatric centre

  2012cites this paper
• Prevention and Treatment of Venous and Arterial Thrombosis in Patients with Specific Conditions: Diabetes, Hypercoagulable States, Pregnancy, and Renal Insufficiency

  2012cites this paper
• Hypercoagulable states.

  2011cites this paper
• Hypercoagulable states.

  2010cites this paper
• Pharmacology and clinical applications of human recombinant antithrombin

  2010cites this paper
• Antithrombin-α for the prophylaxis of venous thrombosis in congenital antithrombin deficiency

  2009cites this paper
• Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates.

  2009cites this paper
• Coagulation activity in liver disease

  2009cites this paper
• Gerinnungsfaktorenkonzentrate

  2008cites this paper
• [Clotting factor concentrates].

  2008cites this paper
• Thrombophilia

  2008cites this paper
• Déficit homozygote en antithrombine de type HBS ; à propos d'une famille

  2007cites this paper
• Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options.

  2007cites this paper
• [Homozygous antithrombin type HBS deficiency; a family study].

  2007cites this paper
• Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study.

  2007cites this paper
• Hereditary and Acquired Antithrombin Deficiency

  2007cites this paper
• Hämostaseologische Diagnostik und Therapie in der Intensivmedizin

  2007cites this paper
• Coagulation factor concentrates: past, present, and future.

  2007cites this paper
• Physiologie und Pathophysiologie von plasmatischer Gerinnung und Fibrinolyse

  2006cites this paper
• A collaborative study to establish a Korea national biological standard for antithrombin concentrate.

  2006cites this paper
• Preoperative antithrombin III activity predicts outcome after surgical repair of acute type A aortic dissection.

  2006cites this paper
• First trimester superior sagittal sinus venous thrombosis and antithrombin deficiency

  2005cites this paper
• Disseminated intravascular coagulation: Present and future perspective

  2005cites this paper
• Perioperative Gerinnungsstörungen

  2004cites this paper
• Sekundärfolgen mechanischer Gewalteinwirkung

  2004cites this paper
• Thrombophilie

  2004cites this paper
• Gerinnungsfaktorenkonzentrate

  2004cites this paper
• Strategies to reduce perioperative blood loss related to non-surgical bleeding

  2003cites this paper
• Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures

  2003cites this paper
• Coagulación y hemorragia en el paciente crítico. Parte II. Factor pronóstico y tratamiento

  2003cites this paper
• Management of thrombophilia

  2003cites this paper
• The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use

  2002cites this paper
• Laboratory thrombophilias and venous thromboembolism

  2002cites this paper
• Antithrombin III in patients admitted to intensive care units: a multicenter observational study

  2002cites this paper
• Treatment of porcine sepsis with high-dose antithrombin III reduces tissue edema and effusion but does not increase risk for bleeding

  2001cites this paper
• [Actions of Antithrombin (AT): experimental and clinical results].

  2001cites this paper
• Recombinant Antithrombin: Production and Role in Cardiovascular Disorder

  2001cites this paper
• Gibt es gesicherte Indikationen für den Einsatz von Antithrombin III in der Intensivmedizin?

  2001cites this paper
• [Are there certified indications for the use of antithrombin III in intensive care].

  2001cites this paper
• Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation

  2001influential citation
• Antithrombin (AT) - Wirkung: Experimentelle und klinische Ergebnisse

  2001cites this paper
• Effects of alpha(2)-macroglobulin and antithrombin on thrombin generation and inhibition in cord and adult plasma.

  2001cites this paper
• Recombinant antithrombin: production and role in cardiovascular disorder.

  2001cites this paper
• Disseminated Intravascular Coagulopathy (DIC): Pathophysiology, Laboratory Diagnosis, and Management

  2000cites this paper
• Measurement of antithrombin activity by thrombin-based and by factor Xa-based chromogenic substrate assays.

  2000cites this paper
• Antithrombin(H) concentrate infusions are safe and effective in patients with thermal injuries.

  2000cites this paper
• The role of antithrombin III in the perioperative management of the patient with unstable angina.

  1999cites this paper
• Antithrombin replacement in patients with sepsis and septic shock.

  1999cites this paper
• [Congenital defects of antithrombin III and proteins C and S during pregnancy].

  1999cites this paper
• Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin.

  1999cites this paper
• Are there specific haemostatic abnormalities in children surviving septic shock with purpura and having skin necrosis or limb ischaemia that need skin grafts or limb amputations?

  1999cites this paper
• Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency – A feasibility pilot study

  1999cites this paper
• Therapeutische Möglichkeiten bei perioperativen Gerinnungsstörungen

  1999cites this paper
• Disseminierte intravasale Gerinnung

  1999cites this paper
• Effekt von Protein C und ATIII auf das Thrombinpotential im Neugeborenenplasma

  1999cites this paper
• Viral etiology of human cancer: a historical perspective.

  1999cites this paper
• Antithrombin activity and antigen

  1999cites this paper
• Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients

  1999cites this paper
• A Collaborative Study to Establish the 2nd International Standard for Antithrombin Concentrate

  1999cites this paper
• Stellenwert des Antithrombin posttraumatisch/perioperativ

  1998cites this paper
• Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

  1998cites this paper
• Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.

  1998cites this paper
• Coagulation disorders in acute renal failure.

  1998cites this paper
• Antithrombin III (ATILL) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study

  1998cites this paper
• Disseminated intravascular coagulation: Clinical and laboratory aspects

  1998cites this paper
• Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.

  1998cites this paper
• Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child.

  1998cites this paper
• Therapeutic applications of antithrombin concentrates in systemic inflammatory disorders.

  1998cites this paper
• Antithrombin (AT) substitution: sense or nonsense?

  1998cites this paper
• A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome.

  1998cites this paper
• Antithrombin und Sepsis

  1998cites this paper
• Hereditärer Antithrombin-Mangel

  1998cites this paper
• Antithrombin und Kombination mit Antikoagulanzien

  1998cites this paper
• Substitutionstherapie mit Antithrombin-Konzentraten bei Leberkrankheiten

  1998cites this paper
• Effects of prostacyclin substitution on systemic procoagulant turnover and cardiorespiratory variables in experimental hypercoagulability.

  1997cites this paper
• Antithrombin III-Independent Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on Acute Thromboembolism in Mice

  1997cites this paper
• The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease

  1997cites this paper
• Management of Acquired Coagulation Disorders in Emergency and Intensive-Care Medicine

  1996cites this paper
• The Management of Abnormalities of Hemostasis in Acute Liver Failure

  1996cites this paper
• [Diagnosis of thrombophilia--cui bono?].

  1996cites this paper
• The Influence of C1-Esterase Inhibitor Substitution on Coagulation and Cardiorespiratory Parameters in an Endotoxin-Induced Rabbit Model of Hypercoagulability

  1996cites this paper
• The management of abnormalities of hemostasis in acute liver failure.

  1996cites this paper
• Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia.

  1996cites this paper
• Bibliography of the Current World Literature

  1995cites this paper